Skip to main content
Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.95
-0.06 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.01 (0.10%)
After-hours: Apr 28, 2026, 4:11 PM EDT

Bioventus Revenue

In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%. Bioventus had revenue of $157.90M in the quarter ending December 31, 2025, with 2.77% growth.

Revenue (ttm)
$568.09M
Revenue Growth
-0.91%
P/S Ratio
1.46
Revenue / Employee
$610,846
Employees
930
Market Cap
830.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025568.09M-5.19M-0.91%
Dec 31, 2024573.28M60.94M11.89%
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 2.73B
Integra LifeSciences Holdings 1.64B
CONMED 1.37B
Lumexa Imaging Holdings 1.02B
Avanos Medical 701.20M
InMode 370.50M
Cytek Biosciences 201.49M
CeriBell 89.06M
Revenue Rankings

BVS News

More News